ANDHealth+ Program 2025

Australia’s leading digital and connected health accelerator

ANDHealth+ is a commercialisation acceleration program for innovative digital and connected health technologies with demonstrable commercial and clinical impact potential.

The two-stage program supports proof-of-concept stage, evidence-based digital and connected health SMEs through:
• Up to $5 million non-dilutive project funding, tranched according to agreed milestones
• Significant in-kind support, specialised expertise and hands-on resources
• A global network of industry advisors, investors, clinicians, executives and corporate partners
• Cohort and alumni-only events and opportunities
• With no equity requirements or IP transfer.
Selected participants will work with a dedicated ANDHealth support team and an Industry Advisory Panel to address and overcome key challenges along the commercialisation pathway.

Each intake, up to five companies are selected via a proven and competitive assessment process, driven by a multi-sectoral, multi-disciplinary group of industry leaders with experience in evaluating and selecting high-potential SMEs.

ANDHealth is supported to deliver the ANDHealth+ program by the Australian Government under the Medical Research Future Fund (MRFF) 2024 BioMedTech Incubator Program.

There will be three intakes under the MRFF BioMedtech Incubator 2024 funding stream, with applications for intake one open now.